 Connection
Michael Schoenbaum to Opiate Substitution Treatment
This is a "connection" page, showing publications Michael Schoenbaum has written about Opiate Substitution Treatment.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.294 |
|
|
|
-
Olfson M, Zhang VS, Schoenbaum M, King M. Trends in Buprenorphine Treatment in the United States, 2009-2018. JAMA. 2020 01 21; 323(3):276-277.
Score: 0.127
-
Watkins KE, Osilla KC, McCullough CM, Griffin BA, Dopp AR, Becker K, Meredith LS, Carrejo V, Hindmarch GM, Mendon-Plasek S, Christensen J, Weir R, Kelly L, Pak L, Murray-Krezan C, Tarhuni L, Crowley C, Bilder A, Kalmin MM, Schoenbaum M, Komaromy M. Collaborative Care for Opioid Use Disorder and Mental Illness: The CLARO Randomized Clinical Trial. JAMA Intern Med. 2026 02 01; 186(2):168-180.
Score: 0.048
-
Fortney JC, Ratzliff AD, Blanchard BE, Ferro L, Rouvere J, Chase E, Duncan MH, Merrill JO, Simpson T, Williams EC, Austin EJ, Curran GM, Schoenbaum M, Heagerty PJ, Saxon AJ. Collaborating to heal addiction and mental health in primary care (CHAMP): A protocol for a hybrid type 2a trial. Contemp Clin Trials. 2024 11; 146:107700.
Score: 0.044
-
Fortney JC, Ratzliff AD, Blanchard BE, Johnson M, Ferro L, Austin EJ, Williams EC, Duncan MH, Merrill JO, Thomas J, Kitay B, Schoenbaum M, Heagerty PJ, Saxon AJ. Does Screening for Opioid Use Disorder in Primary Care Increase the Percentage of Patients With a New Diagnosis? Ann Intern Med. 2023 10; 176(10):1431-1433.
Score: 0.041
-
Olfson M, Zhang V, Schoenbaum M, King M. Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others. Health Aff (Millwood). 2020 06; 39(6):984-992.
Score: 0.033
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|